The KCA recently partnered with two advocacy groups on a blog post examining the relationship between exercise and sickle cell trait. This blog post appears at Sick Cells, a national non-profit advocacy group for sickle…

Dr. Brendan Guercio received a 2023 Interdisciplinary RCC Focus Award for research on “Associations of diet with the gut microbiome among patients with advanced/metastatic RCC receiving immune checkpoint inhibition.” This award was supported by a…

Dr. Niki Zacharias Millward, PhD,  received a 2023 KCA Chromophobe RCC Focus Award for research on “Leveraging patient-derived xenograft models to identify and therapeutically target metabolic hallmarks of chromophobe renal cell carcinoma.” Dr. Millward is…

Dr. Shinji Ohtake received a 2023 Unclassified/Papillary RCC Focus Award for research on the “Development of Models of NF2 loss in papillary and unclassified variant of kidney cancer.” This award was supported by a gift…

Dr. Prateek Khanna received a 2023 KCA Translocation RCC Focus Award for research on “Therapeutic targeting of cell surface antigens in translocation renal cell carcinoma.” This award was given in partnership with Joey’s Wings Foundation,…

Dr. Rana McKay received a 2023 KCA Trailblazer Award for research on “Dissecting predictors of response to immunotherapy in patients with renal cell carcinoma.” Dr. McKay is a medical oncologist at UC San Diego Health…

Dr. Maria Carlo received a 2023 KCA Trailblazer Award for research on the “Role of germline and somatic variants in NRF2 pathway genes in renal cell carcinoma.” Dr. Carlo is a genitourinary oncologist and clinical…

What makes some cancers metastasize and spread or become resistant to treatment? Researchers at MD Anderson developed a model to predict when renal cell carcinoma (RCC), the most common type of kidney cancer, might become…